Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Deconstructing negative symptoms of schizophrenia: avolition-apathy and diminished expression clusters predict clinical presentation and functional outcome.

Strauss GP, Horan WP, Kirkpatrick B, Fischer BA, Keller WR, Miski P, Buchanan RW, Green MF, Carpenter WT Jr.

J Psychiatr Res. 2013 Jun;47(6):783-90. doi: 10.1016/j.jpsychires.2013.01.015. Epub 2013 Feb 27.

2.

Two subdomains of negative symptoms in psychotic disorders: established and confirmed in two large cohorts.

Liemburg E, Castelein S, Stewart R, van der Gaag M, Aleman A, Knegtering H; Genetic Risk and Outcome of Psychosis (GROUP) Investigators.

J Psychiatr Res. 2013 Jun;47(6):718-25. doi: 10.1016/j.jpsychires.2013.01.024. Epub 2013 Mar 6.

3.

The association of neurocognitive impairment with diminished expression and apathy in schizophrenia.

Hartmann-Riemer MN, Hager OM, Kirschner M, Bischof M, Kluge A, Seifritz E, Kaiser S.

Schizophr Res. 2015 Dec;169(1-3):427-432. doi: 10.1016/j.schres.2015.10.032. Epub 2015 Oct 30.

4.

Motivational and neurocognitive deficits are central to the prediction of longitudinal functional outcome in schizophrenia.

Fervaha G, Foussias G, Agid O, Remington G.

Acta Psychiatr Scand. 2014 Oct;130(4):290-9. doi: 10.1111/acps.12289. Epub 2014 May 22.

PMID:
24850369
5.

Categorical and dimensional approaches to negative symptoms of schizophrenia: focus on long-term stability and functional outcome.

Galderisi S, Bucci P, Mucci A, Kirkpatrick B, Pini S, Rossi A, Vita A, Maj M.

Schizophr Res. 2013 Jun;147(1):157-162. doi: 10.1016/j.schres.2013.03.020. Epub 2013 Apr 19.

PMID:
23608244
6.

Neurocognitive impairment in the deficit subtype of schizophrenia.

Fervaha G, Agid O, Foussias G, Siddiqui I, Takeuchi H, Remington G.

Eur Arch Psychiatry Clin Neurosci. 2016 Aug;266(5):397-407. doi: 10.1007/s00406-015-0629-6. Epub 2015 Aug 11.

PMID:
26260899
7.

[Evolution of the concept of apathy: the need for a multifactorial approach in schizophrenia].

Del-Monte J, Capdevielle D, Gély-Nargeot MC, Yazbek H, Pupier F, Boulenger JP, Raffard S.

Encephale. 2013 May;39 Suppl 1:S57-63. doi: 10.1016/j.encep.2012.11.005. Epub 2013 Jan 23. Review. French.

PMID:
23351930
8.

[The clinic of apathy in schizophrenia: a critical review of the issue].

Yazbek H, Raffard S, Del-Monte J, Pupier F, Larue A, Boulenger JP, Gély-Nargeot MC, Capdevielle D.

Encephale. 2014 Jun;40(3):231-9. doi: 10.1016/j.encep.2013.05.002. Epub 2013 Aug 16. Review. French.

PMID:
23958346
9.

Impact of primary negative symptoms on functional outcomes in schizophrenia.

Fervaha G, Foussias G, Agid O, Remington G.

Eur Psychiatry. 2014 Sep;29(7):449-55. doi: 10.1016/j.eurpsy.2014.01.007. Epub 2014 Mar 14.

PMID:
24630742
10.

[Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].

Bralet MC, Navarre M, Eskenazi AM, Lucas-Ross M, Falissard B.

Encephale. 2008 Dec;34(6):557-62. doi: 10.1016/j.encep.2007.12.005. Epub 2008 Jul 9. French.

PMID:
19081451
11.

Avolition, Negative Symptoms, and a Clinical Science Journey and Transition to the Future.

Carpenter WT, Frost KH, Whearty KM, Strauss GP.

Nebr Symp Motiv. 2016;63:133-58. Review.

PMID:
27627826
12.
13.

Assessment of enduring deficit and negative symptom subtypes in schizophrenia.

Mueser KT, Douglas MS, Bellack AS, Morrison RL.

Schizophr Bull. 1991;17(4):565-82.

PMID:
1805350
14.

Differential patterns of premorbid social and academic deterioration in deficit and nondeficit schizophrenia.

Strauss GP, Allen DN, Miski P, Buchanan RW, Kirkpatrick B, Carpenter WT Jr.

Schizophr Res. 2012 Mar;135(1-3):134-8. doi: 10.1016/j.schres.2011.11.007. Epub 2011 Nov 29.

15.
16.

Construct validity of negative symptoms: an empirical and conceptual review.

Earnst KS, Kring AM.

Clin Psychol Rev. 1997;17(2):167-89. Review.

PMID:
9140714
17.

Negative v positive schizophrenia. Definition and validation.

Andreasen NC, Olsen S.

Arch Gen Psychiatry. 1982 Jul;39(7):789-94.

PMID:
7165478
18.

Psychopathology and neuropsychological impairments in deficit and nondeficit schizophrenia of Chinese origin.

Wang X, Yao S, Kirkpatrick B, Shi C, Yi J.

Psychiatry Res. 2008 Mar 15;158(2):195-205. doi: 10.1016/j.psychres.2006.09.007. Epub 2008 Feb 19.

PMID:
18243336
19.

Apathy in schizophrenia as a deficit in the generation of options for action.

Hartmann MN, Kluge A, Kalis A, Mojzisch A, Tobler PN, Kaiser S.

J Abnorm Psychol. 2015 May;124(2):309-18. doi: 10.1037/abn0000048. Epub 2015 Feb 16.

20.

Examining the latent structure of negative symptoms: is there a distinct subtype of negative symptom schizophrenia?

Blanchard JJ, Horan WP, Collins LM.

Schizophr Res. 2005 Sep 15;77(2-3):151-65.

PMID:
15916881

Supplemental Content

Support Center